Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Eli Lilly Partners with AmoyDx and Burning Rock for Retevmo Companion Diagnostics

February 1, 2025
Company

BioNTech’s Comirnaty Gets Limited Authorization in China Amid Scholz Visit

February 1, 2025
Company

Organon’s Q3 Results Show Women’s Health Segment Outperforms Amid Global Revenue Decline

February 1, 2025
CompanyDeals

Organon Signs MOU with China’s National Health Commission at CIIE

February 1, 2025
CompanyDrug

Ascletis Pharma Presents Phase I Study Results for ASC43F at AASLD

February 1, 2025
CompanyDrug

Ji Xing Pharmaceuticals’ Omecamtiv Mecarbil Accepted for Review by CDE

February 1, 2025
CompanyDeals

Sophway Raises ‘Tens of Millions’ in Angel Round for Endoscope Development

February 1, 2025
CompanyDeals

CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment

February 1, 2025
CompanyDeals

CIIE: Bo’ao Lecheng Zone Announces Partnerships with Multinationals

February 1, 2025
Company

Cytiva Announces RMB 60M Investment for China Science Innovation Center at CIIE

February 1, 2025
CompanyDrug

Innovent Biologics’ Tafolecimab Shows Strong LDL-C Reduction in Phase III Study

February 1, 2025
CompanyDrug

Ascentage Pharma Presents APG-1387 Phase I Study Results at AASLD

February 1, 2025
1 2 … 18 19 20 21 22 … 24 25
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up